Dr.JOY Overview
- Year Founded
-
2013

- Status
-
Private
- Latest Deal Type
-
2ndary - Private
- Investors
-
6
Dr.JOY General Information
Description
Developer of a management platform designed to support hospital operations. The company's platform offers attendance management, beacon automatic stamping, in-hospital, regional, and pharmaceutical cooperation and drug and side effect search services, enabling hospitals and other healthcare organizations to operate efficiently.
Contact Information
Website
www.drjoy.jpCorporate Office
- 17th Floor, Toranomon Hills Station Tower
- 2-6-1 Toranomon, Minato-ku
- Tokyo, 105-5517
- Japan
Corporate Office
- 17th Floor, Toranomon Hills Station Tower
- 2-6-1 Toranomon, Minato-ku
- Tokyo, 105-5517
- Japan
Dr.JOY Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Secondary Transaction - Private | Completed | Generating Revenue | ||||
5. Later Stage VC | 01-Aug-2021 | Completed | Generating Revenue | |||
4. Later Stage VC (Series C) | 21-Nov-2019 | Completed | Generating Revenue | |||
3. Early Stage VC (Series B) | 31-Aug-2017 | Completed | Generating Revenue | |||
2. Early Stage VC (Series A) | 30-Sep-2016 | $5.71M | $7.12M | Completed | Generating Revenue | |
1. Seed Round | 07-Oct-2015 | $1.41M | $1.41M | Completed | Generating Revenue |
Dr.JOY Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
C Preferred | ||||||||
B Preferred | ||||||||
A Preferred | 1,265,000 | $4.23 | $4.23 | 1x | $4.23 | 18.88% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Dr.JOY Patents
Dr.JOY Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
JP-7065475-B1 | Leave time determination system, leave time determination device and leave time determination program | Active | 07-Dec-2021 | ||
JP-2023084625-A | Leaving work time determination system, leaving work time determination apparatus, and leaving work time determination program | Active | 07-Dec-2021 | ||
JP-7034449-B1 | Leave time determination system, leave time determination device and leave time determination program | Active | 24-Nov-2021 | ||
JP-2023077327-A | Clock-out time determination system, clock-out time determination device and clock-out time determination program | Active | 24-Nov-2021 | ||
JP-6994728-B1 | Location information acquisition device and location information acquisition program | Active | 05-Aug-2020 |
Dr.JOY Investors (6)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Dentsu Innovation Partners | Corporate Venture Capital | Minority | ||
Itochu | Corporation | Minority | ||
Shinsei Corporate Investment | PE/Buyout | Minority | ||
Suzuken | Corporation | Minority | ||
Femto Partners | Venture Capital | Minority |
Dr.JOY FAQs
-
When was Dr.JOY founded?
Dr.JOY was founded in 2013.
-
Where is Dr.JOY headquartered?
Dr.JOY is headquartered in Tokyo, Japan.
-
What industry is Dr.JOY in?
Dr.JOY’s primary industry is Enterprise Systems (Healthcare).
-
Is Dr.JOY a private or public company?
Dr.JOY is a Private company.
-
What is Dr.JOY’s current revenue?
The current revenue for Dr.JOY is
. -
How much funding has Dr.JOY raised over time?
Dr.JOY has raised $34.3M.
-
Who are Dr.JOY’s investors?
Dentsu Innovation Partners, Itochu, Shinsei Corporate Investment, Suzuken, and Femto Partners are 5 of 6 investors who have invested in Dr.JOY.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »